Helicobacter Pylori Infection, Susceptibility to
4
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
6 treatments under study, led by Bacterial Culture And Drug Sensitivity Test Of Gastric Mucosa Samples
Related Conditions
Often studied with 5 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
25%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
Helicobacter Pylori Infection Among Women With Recurrent Abortion of Unknown Cause
Helicobacter Pylori 23S rRNA/gyrA Gene Mutation Detection Kit (Fluorescence PCR Fusion Curve Method)
Eradication of H. Pylori Infection With Moxifloxacin
Prevalence and Trends of Antimicrobial Resistance of Helicobacter Pylori in Korea
Research Network
Common Treatments
- Bacterial Culture And Drug Sensitivity Test Of Gastric Mucosa Samples1
- Detection Of Fecal Samples With Diagnostic Kit1
- H Pylori Eradication1
- Sequential Regimen Levofloxacin 500 Mg Bid Amoxicillin 1 Gm Bid Omeprazole 20 Mg Bid For First Five Days Followed By Levofloxacin 500 Mgbid Tinidazole 500 Mg Bid Omeprazole 20 Mg Bid1
- Triple Regimen Moxifloxacin 400mg Od Amoxicillin 1 Gm Bid Omeprazole 20mgbid1
Active Sponsors
- Iyad Naeem Muhammad, PhD1
- Assiut University1
- Seoul National University Bundang Hospital1
- Nanjing First Hospital, Nanjing Medical University1
Top Investigators
Nanjing First Hospital, Nanjing Medical University
The First Affiliated Hospital of Zhejiang Chinese Medical University
Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi
The First Affiliated Hospital of Nanchang University
Jiangsu Taizhou People's Hospital
Related Conditions
- Helicobacter Pylori Infection3
- Helicobacter Pylori Associated Gastrointestinal Disease1
- Fecal Drug Resistance Gene Detection1
- Helicobacter Pylori Gyra Levofloxacin Resistance Mutation1
- Helicobacter Pylori 23s Rrna Clarithromycin Resistance Mutation1